For the quarter ending 2025-06-30, IGMS made $143,623K in revenue. $97,584K in net income. Net profit margin of 67.94%.
| Income Statement | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Collaboration revenue | 143,623 | 499 | 721 | 516 |
| General and administrative | 9,581 | 11,049 | 10,548 | 18,761 |
| Research and development | 5,863 | 22,337 | 38,237 | 46,142 |
| Impairment and disposal of long-lived assets | 31,917 | 21,889 | - | - |
| Total operating expenses | 47,361 | 55,275 | 48,785 | 64,903 |
| Income (loss) from operations | 96,262 | -54,776 | -48,064 | -64,387 |
| Interest income | 1,322 | - | 3,276 | 2,957 |
| Total other income | 1,322 | - | 3,276 | 2,957 |
| Loss before income tax expense | - | - | -44,788 | -61,430 |
| Net income (loss) | 97,584 | - | -44,788 | -61,430 |
| Earnings per share, basic, total | 1.59 | -0.86 | -0.743 | -1.01 |
| Earnings per share, diluted, total | 1.58 | -0.86 | -0.743 | -1.01 |
| Weighted average number of shares outstanding, basic, total | 61,462,957 | 61,162,762 | -47,750.333 | 60,657,797 |
| Weighted average number of shares outstanding, diluted, total | 61,751,283 | 61,162,762 | -47,750.333 | 60,657,797 |
IGM Biosciences, Inc. (IGMS)
IGM Biosciences, Inc. (IGMS)